Cipla Limited (CIPLA) — Annual Report Announcement
Cipla Limited announced its 90th Annual General Meeting (AGM) scheduled for 25 June 2026 at 2:00 p.m. IST via video conferencing, alongside its Integrated Annual Report for FY 2025-26. The report highlights a consolidated revenue of ₹28,163 crores, PAT of ₹3,879 crores, and EBITDA of ₹5,925 crores, reflecting strong financial performance. A final dividend of ₹13 per equity share (650% on face value of ₹2) was declared, with payment within 7 working days but not later than 30 days from the AGM. Key governance updates include the re-appointment of Adil Zainulbhai as director and the appointment of B S R & Co. LLP as statutory auditor for a 5-year term. The company emphasized its strategic focus on respiratory care, oncology, and biosimilars, with significant R&D investment of ₹1,974 crores. Sustainability efforts include 84% renewable electricity usage in India and a target of 80% by FY 2029-30. Shareholder engagement details covered e-voting procedures, dividend eligibility, and IEPF compliance for unclaimed amounts.
📄 View Original Announcement (PDF)
About Cipla Limited (CIPLA)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.